Skip navigation

Early anti-smoking drug start seems better: study

NEW YORK (Reuters Health) - Getting a head start on Pfizer's anti-smoking drug Chantix may help smokers kick the habit, according to a preliminary study funded by the company.Full story

Why do clinical trials exclude depressed people?

NEW YORK (Reuters Health) - When the U.S. Food and Drug Administration announced in 2009 that Pfizer Inc's smoking-cessation drug Chantix would need to carry a restrictive "black box" warning label, the move didn't really surprise the market. Full story

Alabama court to hear lawsuit against Pfizer drug

A federal court in Alabama will centralize at least 1,200 civil lawsuits against Pfizer Inc over its smoking-cessation drug Chantix, which plaintiffs say can lead to suicide. Full story

Sponsored Links


Chantix, Zyban must carry depression warning

FDA continues probe of anti-smoking drug

Reports of serious drug reactions set a record

FAA bans Chantix for pilots, traffic controllers

Conflict over officials’ stop-smoking advice


  FDA puts two drugs on suicide watch

July 1: The FDA on Wednesday warned that anyone taking Chantix and Zyban should be watched closely for signs of mental illness because of a growing number of reports of suicide among patients who take the drugs. NBC's Brian Williams reports.